TrialResults - center   -  Clinical trials results database in


cardiology database


AHA 2011 Orlando conference coverage

News clinical trials presented at AHA 2011 Orlando


ADOPT, 2011 - apixaban 2.5mg twice daily, 30 days vs enoxaparin 40mg once daily 6-14 days

  DVT prophylaxis - antithrombotics - medical patients

  DVT prophylaxis - direct factor Xa inhibitors - all type of patients

  DVT prophylaxis - new oral anticoagulants - all type of patients

  DVT prophylaxis - new oral anticoagulants - medical patients

ATLAS ACS 2 - TIMI 51 (2.5mg), 2011 - rivaroxaban 2.5 mg twice daily in addition to standard care vs placebo

  acute coronary syndrome - antithrombotics - all type of patient

  acute coronary syndrome - anticoagulant - All ACS (including AMI)

  acute coronary syndrome - direct factor Xa inhibitors - all type of patients

  acute coronary syndrome - antithrombotics - patients with a recent ACS

  acute coronary syndrome - new oral anticoagulants - all type of patients

FAST, 2011 - vs



Choose another conferences:

  • AHA 2012 Los Angeles
  • ESC 2012 München
  • AHA 2011 Orlando
  • TCT 2011
  • ESC 2011 Paris
  • ACC 2011 New Orleans
  • ESC 2010 Stockholm
  • ACC 2010 Atlanta
  • European Society of Cardiology 2009 Congress
  • ACC.09/i2 Orlando 2009
  • AHA 2009 Orlando
  • TCT 2010
  • AHA 2010 Chicago
  • ACC 2012



  •  


    (c) 2006-2013TrialResults-center - All rights reserved Sitemap | Feedback | Disclaimer & Privacy Policy | Copyright | Home | Top
    Last uptaded on 2013/12
    116 user(s) connected

    Creative Commons License TrialResults-center database by TrialResults-center is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France License .


    OpenSearch feed - Add TrialResults-center.org to your browser's search bar